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Valorisation 
Valorisation is the process of creating value out of knowledge. It is about translating 
scientific knowledge into practice. The societal value of the different studies in this 
dissertation is already discussed in the individual chapters. We now summarise the 
implications of the major findings of this dissertation. We will discuss this in three 
parts: societal relevance, target groups, products and innovation, and realisation. 
Societal relevance 
As described previously in this dissertation, COPD is a major public and individual 
health problem. In the Netherlands, around 607,000 people had COPD in 20151. Due to 
exacerbations and comorbidities a lot of these patients end up in hospital every now 
and then. Besides, approximately 6,400 people died in the Netherlands in 2015 with 
COPD as the primary cause1. Due to sick leave and premature disability or death this 
results in a huge economic burden; in the Netherlands, smoking-related health care 
costs amount around 3 billion euro1, while costs for COPD and asthma care amount 
more than 1.5 billion euro1. Giving up smoking is the most effective way to prevent the 
disease from worsening and, therefore, delay premature disability and death2,  3.
However, in the general discussion (Chapter 7) we described that many smokers are 
not able to quit due to psychological and social factors. Thus, it is of utmost importance 
for patients with COPD to be supported in their attempts to quit smoking. We will 
discuss how this support can be effectively offered.    
Target groups, products and innovation 
Physicians and other health care providers 
The first health care contact with smokers is often with the general practitioner. 
Therefore, general practitioners are a significant target group to discuss smoking 
behaviour with patients and support them with quitting. In the Netherlands, practice 
nurses expand their activities increasingly and most practices also facilitate nurses for 
support. These nurses are often the right persons to offer smoking cessation support to 
the patients. Most of the chronic care, including COPD care, is delivered by practice 
nurses as well, which makes them the designated person to provide smoking cessation 
treatment to smokers with COPD. For smoking cessation support in general practice 
the smoking cessation guideline from the Dutch College of General Practitioners is 
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most often used4. Unfortunately, a lot of physicians do not seem to comply with these 
guidelines. 
In Chapter 4 and 6 we gained further insight into the quality of the smoking cessation 
support from physicians. We found that autonomy was very important for smokers in 
general and patients with COPD in particular requested a less paternalistic doctor-
patient communication. They also indicated they would appreciate receiving some 
personal attention from their physicians, with exploration of social interactions, health 
perceptions, feelings and concerns. Physicians, on the other hand, indicated they 
needed tools and guidance in how to support smokers with quitting. Therefore, we 
would recommend introducing an informative smoking cessation program with 
teaching of evidence-based smoking cessation treatments and communication, into 
the vocational training and postgraduate medical training. Because, if doctors are not 
well-informed and motivated, then how can patients be? 
Guideline developers 
The previously mentioned smoking cessation guidelines, used in general practices, 
discuss general smoking cessation issues and attitudes. We would suggest to add 
patient-specific advices to these general guidelines, such as paying special attention to 
discuss depressive symptoms, nicotine dependence and self-efficacy, as these factors 
might be COPD-specific barriers to quitting. This might also be useful for other specific 
groups of patients. Therefore, it would be useful to further map out which specific 
patients need what kind of specific attention. 
Services
In the introduction of this chapter we already mentioned that smoking cessation 
treatments that are provided are not often used, and we know from this dissertation 
that lack of time and experience (Chapter 6) are often mentioned as barriers for 
providing smoking cessation advice. It might therefore be interesting to look into the 
effectiveness of smoking cessation support services. At the moment the United 
Kingdom (UK) offers the world’s most comprehensive support for smokers to quit5.
Stop Smoking Services have been established throughout the UK. Some are under local 
authority control, others remain as part of the National Health Services. These services 
offer practical support and pharmaceutical treatments on prescription to help smokers 
to give up at no or very low cost5. These services show great promise. In the 
Valorisation 
181
Netherlands, we do not have such large-scale services. The ones that we have are 
rather  hard  to  find  and  not  free  of  cost.  It  is  interesting  to  notice  that  we  do  have  
clinics with multidisciplinary treatment of eating disorders or other drug addictions. 
Unfortunately, for nicotine addiction there are no such facilities and on the basis of the 
results of this dissertation we would argue in favour of such service facilities. 
Government 
Governments have the obligation to care for the health of the residents. Governmental 
actions such as raising taxes are extremely cost-effective interventions to reduce 
tobacco use and prevent COPD6. The tobacco industry contradicts this information, but 
their arguments are not evidence-based. They state that raising taxes will lead to more 
illicit trade and smuggling. The only evidence that does exist is that increase in cigarette 
taxes  and  the  passage  of  comprehensive  clean  air  laws  are  the  cornerstone  of  
strategies that have been successful in reducing smoking rates6. These tax revenues 
could then be used for tobacco control, health promotion and other public health 
interventions. Mass media campaigns and cessation policies also play an important role 
in reducing the smoking rates6. In the Netherlands, we saw that a national 
reimbursement policy accompanied by media attention was followed by an increase in 
quit attempts and quit rates7. An increased use of cessation treatments was one of the 
reasons for this8,  9. Furthermore, as previously mentioned, in the Netherlands, 
commercial cessation methods are widely promoted and people lack knowledge of 
evidence-based smoking cessation treatments10. Therefore, it is highly recommended 
that evidence-based smoking cessation methods are promoted and alternative, non- 
evidence-based treatments, are not advocated. Campaigns on the health 
consequences of smoking are very important too. 
Realization 
We will discuss the main findings from this dissertation with the vocational training 
institute with the recommendation of introducing an informative smoking cessation 
program. We can assist in the development of such a training program. Furthermore, 
we will advise the Dutch College of General Practitioners guideline panel to consider 
adding COPD-specific elements to the next update of the smoking cessation guideline. 
We advise researchers to further map out which additional information is needed in 
the guideline for other specific patient groups. 
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